JURABUTIKKEN ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.0% 2.3% 6.3% 11.2% 5.4%  
Credit score (0-100)  17 65 36 21 41  
Credit rating  BB BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  338 935 1,019 454 454  
EBITDA  15.1 742 524 31.4 16.9  
EBIT  15.1 668 473 31.4 16.9  
Pre-tax profit (PTP)  15.0 665.1 444.8 28.4 16.9  
Net earnings  15.0 507.6 347.0 16.6 13.1  
Pre-tax profit without non-rec. items  15.0 665 445 28.4 16.9  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 946 0.0 0.0 0.0  
Shareholders equity total  65.0 573 390 214 227  
Interest-bearing liabilities  0.1 863 65.3 2.4 10.9  
Balance sheet total (assets)  96.1 1,649 968 553 396  

Net Debt  -86.7 171 -902 -550 -313  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  338 935 1,019 454 454  
Gross profit growth  0.0% 176.9% 9.0% -55.4% -0.0%  
Employees  1 1 0 0 0  
Employee growth %  0.0% -23.1% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 -437.3  
Balance sheet total (assets)  96 1,649 968 553 396  
Balance sheet change%  0.0% 1,616.0% -41.3% -42.9% -28.3%  
Added value  15.1 742.4 524.3 82.7 454.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 872 -997 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.5% 71.4% 46.4% 6.9% 3.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.7% 76.6% 36.2% 4.1% 3.6%  
ROI %  23.2% 89.1% 50.0% 9.3% 7.4%  
ROE %  23.0% 159.2% 72.1% 5.5% 6.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  67.6% 34.7% 40.3% 38.6% 57.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -574.8% 23.0% -172.1% -1,754.0% -1,853.4%  
Gearing %  0.2% 150.7% 16.7% 1.1% 4.8%  
Net interest  0 0 0 0 0  
Financing costs %  211.9% 0.7% 6.1% 8.9% 0.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.1 0.9 1.7 1.6 2.3  
Current Ratio  3.1 0.9 1.7 1.6 2.3  
Cash and cash equivalent  86.8 692.5 967.7 552.7 323.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  65.0 -73.5 390.3 213.5 226.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  12 742 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  12 742 0 0 0  
EBIT / employee  12 668 0 0 0  
Net earnings / employee  12 508 0 0 0